These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 29433700)

  • 1. A Literature Review of Cervical Cancer Screening in Transgender Men.
    Gatos KC
    Nurs Womens Health; 2018 Feb; 22(1):52-62. PubMed ID: 29433700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Female-to-male patients have high prevalence of unsatisfactory Paps compared to non-transgender females: implications for cervical cancer screening.
    Peitzmeier SM; Reisner SL; Harigopal P; Potter J
    J Gen Intern Med; 2014 May; 29(5):778-84. PubMed ID: 24424775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pap test use is lower among female-to-male patients than non-transgender women.
    Peitzmeier SM; Khullar K; Reisner SL; Potter J
    Am J Prev Med; 2014 Dec; 47(6):808-12. PubMed ID: 25455121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Understanding Transgender Men's Experiences with and Preferences for Cervical Cancer Screening: A Rapid Assessment Survey.
    Seay J; Ranck A; Weiss R; Salgado C; Fein L; Kobetz E
    LGBT Health; 2017 Aug; 4(4):304-309. PubMed ID: 28422558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cervical Cancer Screening for Patients on the Female-to-Male Spectrum: a Narrative Review and Guide for Clinicians.
    Potter J; Peitzmeier SM; Bernstein I; Reisner SL; Alizaga NM; Agénor M; Pardee DJ
    J Gen Intern Med; 2015 Dec; 30(12):1857-64. PubMed ID: 26160483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perceptions of cervical cancer risk and screening among transmasculine individuals: patient and provider perspectives.
    Agénor M; Peitzmeier SM; Bernstein IM; McDowell M; Alizaga NM; Reisner SL; Pardee DJ; Potter J
    Cult Health Sex; 2016 Oct; 18(10):1192-206. PubMed ID: 27142466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bridging Barriers to Cervical Cancer Screening in Transgender Men: A Scoping Review.
    Dhillon N; Oliffe JL; Kelly MT; Krist J
    Am J Mens Health; 2020; 14(3):1557988320925691. PubMed ID: 32489142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gynecologic Health Care Providers' Willingness to Provide Routine Care and Papanicolaou Tests for Transmasculine Individuals.
    Shires DA; Prieto L; Woodford MR; Jaffee KD; Stroumsa D
    J Womens Health (Larchmt); 2019 Nov; 28(11):1487-1492. PubMed ID: 31411513
    [No Abstract]   [Full Text] [Related]  

  • 9. Breast and Cervical Cancer Screening Disparities in Transgender People.
    Oladeru OT; Ma SJ; Miccio JA; Wang K; Attwood K; Singh AK; Haas-Kogan DA; Neira PM
    Am J Clin Oncol; 2022 Mar; 45(3):116-121. PubMed ID: 35195561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cervical cancer prevention in transgender men: a review.
    Weyers S; Garland SM; Cruickshank M; Kyrgiou M; Arbyn M
    BJOG; 2021 Apr; 128(5):822-826. PubMed ID: 32931650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human Papillomavirus-Related Cancer Surveillance, Prevention, and Screening Among Transgender Men and Women: Neglected Populations at High Risk.
    Brown B; Poteat T; Marg L; Galea JT
    LGBT Health; 2017 Oct; 4(5):315-319. PubMed ID: 28876211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The renewal of the National Cervical Screening Program.
    Carter J
    Med J Aust; 2016 Oct; 205(8):357-358. PubMed ID: 27736622
    [No Abstract]   [Full Text] [Related]  

  • 13. Transgender and non-binary peoples experiences of cervical cancer screening: A scoping review.
    Rivers G; Hinchliff S; Thompson J
    J Clin Nurs; 2024 Jun; 33(6):2112-2122. PubMed ID: 38334194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer screening rates among transgender adults: Cross-sectional analysis of primary care data.
    Kiran T; Davie S; Singh D; Hranilovic S; Pinto AD; Abramovich A; Lofters A
    Can Fam Physician; 2019 Jan; 65(1):e30-e37. PubMed ID: 30674526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cervical cancer risk levels in Turkey and compliance to the national cervical cancer screening standard.
    Açikgöz A; Ergör G
    Asian Pac J Cancer Prev; 2011; 12(4):923-7. PubMed ID: 21790227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. "It Can Promote an Existential Crisis": Factors Influencing Pap Test Acceptability and Utilization Among Transmasculine Individuals.
    Peitzmeier SM; Agénor M; Bernstein IM; McDowell M; Alizaga NM; Reisner SL; Pardee DJ; Potter J
    Qual Health Res; 2017 Dec; 27(14):2138-2149. PubMed ID: 28836483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Developing a hand-held Pap test card to improve cervical cancer screening.
    Prendergast MB; Hunter LP
    Nurs Womens Health; 2014; 18(3):212-9. PubMed ID: 24939198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes on the horizon for cervical cancer screening.
    Isidean SD; Shinder GA
    Prev Med; 2017 May; 98():1-2. PubMed ID: 28034732
    [No Abstract]   [Full Text] [Related]  

  • 19. Cervical Cancer Screening for Women Living with HIV.
    Chapman CL; Harris AL
    Nurs Womens Health; 2016; 20(4):392-8. PubMed ID: 27520603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Annual Gynecologic Examination Updated for the 21st Century.
    Cappiello J; Levi A
    Nurs Womens Health; 2016; 20(3):315-9. PubMed ID: 27287359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.